186 related articles for article (PubMed ID: 35011397)
1. Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.
Anwer MK; Ali EA; Iqbal M; Ahmed MM; Aldawsari MF; Saqr AA; Ansari MN; Aboudzadeh MA
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011397
[TBL] [Abstract][Full Text] [Related]
2. Improved oral delivery of tilianin through lipid-polymer hybrid nanoparticles to enhance bioavailability.
Zeng C; Zheng R; Yang X; Du Y; Xing J; Lan W
Biochem Biophys Res Commun; 2019 Nov; 519(2):316-322. PubMed ID: 31506175
[TBL] [Abstract][Full Text] [Related]
3. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.
Anwer MK; Mohammad M; Ezzeldin E; Fatima F; Alalaiwe A; Iqbal M
Int J Nanomedicine; 2019; 14():1587-1595. PubMed ID: 30880967
[TBL] [Abstract][Full Text] [Related]
4. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system.
Shakeel F; Iqbal M; Ezzeldin E
J Pharm Pharmacol; 2016 Jun; 68(6):772-80. PubMed ID: 27018771
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.
Zhao X; Sheng XY; Payne CD; Zhang X; Wang F; Cui YM
Clin Pharmacol Drug Dev; 2020 Nov; 9(8):952-960. PubMed ID: 32945153
[TBL] [Abstract][Full Text] [Related]
8. A Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry Quantitative Method for Determination of Baricitinib in Plasma, and Its Application in a Pharmacokinetic Study in Rats.
Ezzeldin E; Iqbal M; Asiri YA; Ali AA; Alam P; El-Nahhas T
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244454
[TBL] [Abstract][Full Text] [Related]
9. Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.
Hanna LA; Basalious EB; ELGazayerly ON
Drug Deliv; 2016 Nov; 24(1):188-198. PubMed ID: 28156176
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
11. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du X; Gao N; Song X
Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
[TBL] [Abstract][Full Text] [Related]
12. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
[No Abstract] [Full Text] [Related]
13. Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles.
Cooper DL; Harirforoosh S
PLoS One; 2014; 9(12):e113558. PubMed ID: 25502102
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.
Sun D; Xue A; Zhang B; Xue X; Zhang J; Liu W
Drug Des Devel Ther; 2016; 10():2029-39. PubMed ID: 27382256
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery.
Palamoor M; Jablonski MM
Colloids Surf B Biointerfaces; 2013 Dec; 112():474-82. PubMed ID: 24103464
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system.
Ammar HO; Ghorab MM; Mahmoud AA; Higazy IM
Eur J Pharm Sci; 2018 Mar; 115():77-87. PubMed ID: 29341900
[TBL] [Abstract][Full Text] [Related]
17. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
18. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
[TBL] [Abstract][Full Text] [Related]
19. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
Jain S; Valvi PU; Swarnakar NK; Thanki K
Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
[TBL] [Abstract][Full Text] [Related]
20. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]